Anabelle Colaco
03 Aug 2025, 16:05 GMT+10
FREMONT, California: Elon Musk's Neuralink is taking its brain-computer interface technology to the UK, with a clinical trial aimed at helping patients with severe paralysis operate devices using only their thoughts.
The company announced it will partner with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.
Neuralink said the trial will involve patients suffering from conditions like spinal cord injuries and Amyotrophic Lateral Sclerosis (ALS). These individuals may qualify to test the company's implant, which is designed to enable control of digital and physical tools via brain signals.
The UK study comes as part of Neuralink's broader efforts to scale human testing of its brain chip. The company began human trials in 2024 after addressing safety issues flagged by the U.S. Food and Drug Administration, which initially rejected its application in 2022.
According to Neuralink, five patients with severe paralysis are already using the device to control external tools with their thoughts.
Founded in 2016, Neuralink has raised about US$1.3 billion from investors and is reportedly valued at approximately $9 billion, according to PitchBook data cited in media reports.
Last month, the company secured $650 million in fresh funding to advance its work on brain-machine interfaces.
Get a daily dose of San Francisco Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to San Francisco Star.
More InformationWASHINGTON, D.C.: On August 1, President Donald Trump escalated his feud with Federal Reserve Chair Jerome Powell, urging the central...
WASHINGTON, D.C.: The U.S. labor market lost momentum in July, with job growth slowing more than expected and major downward revisions...
SAN FRANCISCO, California: Apple projected stronger-than-expected revenue for the current quarter ending in September, helping lift...
SEATTLE, Washington: More than a year after a door panel ripped off a Boeing 737 MAX 9 mid-flight, four flight attendants who were...
FREMONT, California: Elon Musk's Neuralink is taking its brain-computer interface technology to the UK, with a clinical trial aimed...
SEATTLE, Washington: Starbucks expressed confidence this week that a combination of streamlined store operations and new menu offerings—such...
WASHINGTON, D.C.: On August 1, President Donald Trump escalated his feud with Federal Reserve Chair Jerome Powell, urging the central...
The International Red Cross's affiliated Palestine Red Crescent Society (PRCS) has accused Israeli forces of deliberately targeting...
DEIR AL-BALAH, Gaza Strip: U.S. President Donald Trump's special envoy, Steve Witkoff, arrived in Israel this week to address the worsening...
FREMONT, California: Elon Musk's Neuralink is taking its brain-computer interface technology to the UK, with a clinical trial aimed...
WASHINGTON, D.C.: U.S. President Donald Trump has ordered the White House to get a significant new addition: a US$200 million, 90,000-square-foot...
CAPE CANAVERAL, Florida: In a powerful display of international collaboration, NASA and the Indian Space Research Organization (ISRO)...
